Long-term safety of treating sPTRCT with injection of either UA-ADRCs or corticosteroid
TEAEs
The subjects in the UA-ADRCs group reported a total number of 58 TEAEs (35 TEAEs during the former studyNo TEAE that occurred during the present and the former studiesAll subjects reported experiencing at least one TEAE. The number of subjects who experienced 1/2/3/4/6/7/8/10/12 TEAEs in the present and the former studiesThe number of TEAEs classified as {mild/moderate/severe} in the present and the former studiesThe relationship of TEAEs to treatment classified as {not related/unlikely/possible/probable/definite} in the present and the former studiesThe number of TEAEs classified as {mild and unlikely to be related to the investigated treatment/mild and possibly related to the investigated treatment/moderate and unlikely to be related to the investigated treatment/moderate and possibly related to the investigated treatment} in the present and the former studiesThe four severe TEAEs that occurred in the UA-ADRCs group during the present and the former studies